News
MYCOF
0.132
NaN%
--
Weekly Report: what happened at MYCOF last week (1208-1212)?
Weekly Report · 12h ago
Weekly Report: what happened at MYCOF last week (1201-1205)?
Weekly Report · 12/08 10:01
Weekly Report: what happened at MYCOF last week (1124-1128)?
Weekly Report · 12/01 09:58
Weekly Report: what happened at MYCOF last week (1117-1121)?
Weekly Report · 11/24 10:01
Weekly Report: what happened at MYCOD last week (1110-1114)?
Weekly Report · 11/17 10:01
Weekly Report: what happened at MYCOD last week (1103-1107)?
Weekly Report · 11/10 09:59
Weekly Report: what happened at MYCOD last week (1027-1031)?
Weekly Report · 11/03 09:59
Weekly Report: what happened at MYCOD last week (1020-1024)?
Weekly Report · 10/27 10:02
Weekly Report: what happened at MYCOF last week (1013-1017)?
Weekly Report · 10/20 09:59
Weekly Report: what happened at MYCOF last week (1006-1010)?
Weekly Report · 10/13 10:01
Weekly Report: what happened at MYCOF last week (0929-1003)?
Weekly Report · 10/06 09:59
Weekly Report: what happened at MYCOF last week (0922-0926)?
Weekly Report · 09/29 09:59
Weekly Report: what happened at MYCOF last week (0915-0919)?
Weekly Report · 09/22 09:59
Weekly Report: what happened at MYCOF last week (0908-0912)?
Weekly Report · 09/15 09:51
Weekly Report: what happened at MYCOF last week (0901-0905)?
Weekly Report · 09/08 09:52
Weekly Report: what happened at MYCOF last week (0825-0829)?
Weekly Report · 09/01 09:50
Weekly Report: what happened at MYCOF last week (0818-0822)?
Weekly Report · 08/25 09:54
Weekly Report: what happened at MYCOF last week (0811-0815)?
Weekly Report · 08/18 09:51
Weekly Report: what happened at MYCOF last week (0804-0808)?
Weekly Report · 08/11 09:54
Weekly Report: what happened at MYCOF last week (0728-0801)?
Weekly Report · 08/04 09:55
More
Webull provides a variety of real-time MYCOF stock news. You can receive the latest news about Mydecine Innovations Group Inc through multiple platforms. This information may help you make smarter investment decisions.
About MYCOF
Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing the next generation of medications and therapies to address mental health disorders, such as nicotine addiction and post traumatic stress disorder (PTSD). The Company conducts research and development on novel second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It uses advanced artificial intelligence (AI) and machine learning to design and screen drugs of interest. Its subsidiaries include Mydecine Group (1220611 BC Ltd) and NeuroPharm Inc.